Skip to content

Effect of Ambrosia artemisiaefolia and Individualized Homoeopathic Medicine in management of allergic rhinitis

ASSESSING THE EFFECT OF AMBROSIA ARTEMISIAEFOLIA AND INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF ALLERGIC RHINITIS IN ADULT POPULATION: A COMPARATIVE RANDOMIZED CLINICAL STUDY - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077830
Enrollment
68
Registered
2024-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines: Pill form, 30 pill size, oral route of administration ,centesimal potency, first dose at the time of case taking subsequent doses according to fol

Sponsors

Principal Bakson Homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed participants(new and old) of Allergic Rhinitis. Participants from 20–59 years age group, both male and female. Participants who had taken any Anti – allergic medicines for Allergic Rhinitis willing to have homoeopathic treatment will be enrolled after washout period of 2 weeks. New cases of allergic rhinitis will be diagnosed by clinical and physical examination .

Exclusion criteria

Exclusion criteria: Participants with other Upper respiratory tract infection (Laryngitis, Pharyngitis, Diphtheria, Etc.) Participants with Lower respiratory tract infection (Chronic bronchitis, Bronchial Asthma, Pulmonary Tuberculosis) Gross nasal developmental defects or structural abnormalities causing obstruction, e.g., nasal polyp(s), deviated septum etc. Participants on steroid treatment. Pregnant and Lactating females.

Design outcomes

Primary

MeasureTime frame
Decrease in TNSS Scale to signify improvement in Allergic Rhinitis.Timepoint: TNSS Scale will be used at baseline, every 4 weeks upto 24 weeks. 15 month study. 6 months enrolment 6 months follow up 3months analysis first dose at the time of case taking and subsequent doses according to follow ups.

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Ashwini Nair

Bakson homoeopathic medical college and hospital

pginchargebakson@gmail.com9990178024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026